Last reviewed · How we verify
NCT05289531
(LARS) Score Validation of Turkish Language
trial testing Rectal Resection Patients in LARS - Low Anterior Resection Syndrome in 222 participants. Completed in 28 February 2020.
28 February 2020
Quick facts
| Lead sponsor | Ankara University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 222 |
| Start date | 1 February 2016 |
| Primary completion | 28 February 2020 |
| Estimated completion | 28 February 2020 |
Drugs / interventions tested
- Rectal Resection Patients
Conditions studied
- LARS - Low Anterior Resection Syndrome — all drugs for LARS - Low Anterior Resection Syndrome →
Sponsor
Ankara University
Who can join
18 and older, any sex, with LARS - Low Anterior Resection Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Long-term bowel dysfunction after resection for rectal cancer, known as low anterior resection syndrome (LARS), is observed in many patients. The LARS score was developed to measure this syndrome and its impact on quality of life in Danish patients. Recently, English and many other language versions have been validated. The aim of this study was to validate the Turkish translation of the LARS score in Turkish patients who have undergone treatment for rectal cancer.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Validation of the Turkish translation of the low anterior resection syndrome (LARS) score.
Celasin H, Akyol C, Gecim IE, Halil Elhan A, et al · · 2023 · cited 4× · PMID 36650405 · DOI 10.1007/s10151-023-02751-z
Verify or expand the search:
- PubMed search for NCT05289531
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for LARS - Low Anterior Resection Syndrome
Currently open trials in the same condition.
- NCT07071987 — Effect of Thread Embedding Acupuncture on Postoperative Ileus Recovery After Colorectal Cancer Surgery: A Multicenter Ra · NA · recruiting
Other Ankara University trials
Trials by the same sponsor.
- NCT07441837 — Terbium 161 PSMA in Lutetium-177 PSMA Naive Patients · Phase 2 · not yet recruiting
- NCT07536490 — Sleep Quality, Cognition, and Disease Severity in Parkinson's Disease · not yet recruiting
- NCT06959433 — Lu-177 PSMA Treatment in Cell Renal Carcinoma · Phase 3 · not yet recruiting
- NCT07513272 — EFFECT OF BALLS ON PAIN AND ANXIETY DURING VENIPUNCTURE IN CHILDREN · NA · not yet recruiting
- NCT07536542 — Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05289531 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ankara University
- Last refreshed: 21 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05289531.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing